Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
157 studies found for:    "restless legs syndrome"
Show Display Options
Rank Status Study
21 Unknown  Neuroma Injections to Treat Restless Legs Syndrome - RCT
Condition: Restless Legs Syndrome
Interventions: Drug: equal parts of 0.5% plain Marcaine and 2% lidocaine mixed with 0.8 mg Depo-medrol/4% absolute alcohol in a total injection volume of 1 ml;   Drug: Normal saline - 1ml
22 Active, not recruiting Cranial Electrotherapy for Military Beneficiaries With Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Device: Active CES Device Alpha-Stim®;   Device: Sham Device
23 Completed RESTIFFIC™ Foot Wrap Reduces Moderate to Severe Restless Leg Syndrome
Condition: Restless Leg Syndrome
Intervention: Device: RESTIFFIC™ Brand Pressure Application System
24 Unknown  Executive Dysfunction in Restless Legs Syndrome: Clinical Correlates and Outcome After Therapeutic Management
Condition: Restless Legs Syndrome
Interventions: Other: Polysomnography;   Other: Clinical Scales;   Other: Assessment of executive functions;   Other: Medical consultation
25 Withdrawn Pregabalin (Lyrica) for the Treatment of Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: Pregabalin (Lyrica);   Drug: Placebo
26 Completed ASP8825 - Study in Patients With Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: ASP8825;   Drug: Placebo
27 Completed Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients
Condition: Restless Legs Syndrome
Intervention: Drug: ASP8825
28 Unknown  Apelin in Willis Ekbom Disease
Condition: Restless Legs Syndrome
Intervention:
29 Completed
Has Results
Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients
Condition: Idiopathic Restless Legs Syndrome
Interventions: Drug: placebo and pregabalin;   Drug: pramipexol;   Drug: Pregabalin
30 Unknown  Efficacy of Tyrosine in Restless Legs Syndrome
Condition: Restless Legs Syndrome (RLS)
Intervention: Dietary Supplement: L-Tyrosine
31 Completed
Has Results
Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)
Condition: Restless Legs Syndrome
Interventions: Drug: Rotigotine;   Other: Placebo
32 Completed Phase 3 Open-label Extension Trial With Rotigotine in Idiopathic Restless Legs Syndrome Subjects
Condition: Idiopathic Restless Legs Syndrome
Intervention: Drug: Rotigotine
33 Withdrawn Butrans for Treatment of Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: buprenorphine transdermal delivery system (BTDS);   Drug: Placebo for BTDS patch
34 Completed Altered Brain GABA and Glutamate in Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention:
35 Completed Sequential Compression Devices for Treatment of Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Device: AirCast Sequential Compression Device
36 Completed Efficacy and Safety Study of Topiramate to Treat Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Topiramate
37 Completed
Has Results
Long-term Study Of Ropinirole In Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: Placebo;   Drug: Ropinirole
38 Completed Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)
Condition: Restless Legs Syndrome
Interventions: Drug: Lisuride;   Drug: Ropinirole;   Drug: Placebo
39 Completed
Has Results
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Rotigotine
40 Completed
Has Results
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Rotigotine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.